bovnews3h
Trevi Therapeutics Inc (TRVI) Stock Rated Outperform by Leerink Partners
Notable insider trades include GOOD JENNIFER L, President & CEO at Trevi Therapeutics Inc (TRVI), who sold 40277 shares on Sep 05 ’24, at $3.11 each, totaling $0.13 million. On May 29 ’24, SCIASCIA ...
FiercePharma56m
In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines
With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...
Leerink Partnrs Issues Positive Estimate for Opthea Earnings
Analysts at Leerink Partnrs lifted their FY2025 EPS estimates for shares of Opthea in a report released on Tuesday, October ...
AbbVie: Balanced Outlook Amid EPS Adjustments and Pipeline Uncertainties Warrants Hold Rating
David Risinger, an analyst from Leerink Partners, maintained the Hold rating on AbbVie (ABBV – Research Report). The associated price ...
Mind Medicine assumed with an Outperform at Leerink
Leerink assumed coverage of Mind Medicine with an Outperform rating and $20 price target The firm likes the emerging ...
Leerink Partnrs Has Negative Outlook of Biohaven Q3 Earnings
Research analysts at Leerink Partnrs cut their Q3 2024 earnings per share (EPS) estimates for Biohaven in a report released ...
Nasdaq28d
Leerink Partners Initiates Coverage of Voyager Therapeutics (VYGR) with Outperform Recommendation
Fintel reports that on October 16, 2024, Leerink Partners initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a Outperform recommendation. As of September 25, 2024, the average one ...
Leerink Partners' Affiliate, MEDACorp, Launches the Center for Pharmacoeconomics to Evaluate the Societal Impact of Healthcare Treatments
Leerink Partners' affiliate, MEDACorp, announced today the launch of a new division, the Center for Pharmacoeconomics (CPE), which will be dedicated to advancing the understanding of the societal ...